We are live on
!
Find out more
MMRF
Michelson Medical Research Foundation Portfolio holdings
AUM
$108M
1-Year Est. Return
29.95%
This Fund
S&P 500
This Quarter
Est. Return
+11.71%
1 Year Est. Return
+29.95%
3 Year Est. Return
+52.22%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$115M
AUM Growth
+$10.8M
(+10%)
Cap. Flow
+$699K
Cap. Flow
% of AUM
0.61%
Top 10 Holdings %
Top 10 Hldgs %
79.7%
Holding
21
New
1
Increased
–
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$11.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 11.18% |
| 2 | Financials | 6.2% |
| 3 | Real Estate | 4.01% |
| 4 | Communication Services | 2.63% |
| 5 | Energy | 1.21% |
Similar funds
SA
BC
SF
UFA
YEPX
YAIA
BCM
RRA
Michelson Medical Research Foundation's Q3 2025 Portfolio in Review
As of Q3 2025, Michelson Medical Research Foundation held 21 positions worth $115M, up 10% from $104M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Michelson Medical Research Foundation's Q3 2025 filing shows 1 new and 1 closed positions. Its largest new stake was iShares 0-3 Month Treasury Bond ETF: 116,226 shares worth $11.7M. The largest sale was Rentokil, an estimated $11M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 11% of assets, down from 13% a quarter earlier, followed by Financials and Real Estate.
- Michelson Medical Research Foundation's largest Q3 2025 buy was iShares 0-3 Month Treasury Bond ETF: 116,226 shares worth $11.7M.
- Michelson Medical Research Foundation fully exited Rentokil in Q3 2025, selling an estimated $11M.
- Michelson Medical Research Foundation's ten largest holdings make up 80% of its $115M portfolio in Q3 2025.
- Michelson Medical Research Foundation opened 1 new position and closed 1 in Q3 2025.
- Michelson Medical Research Foundation's portfolio value rose 10% quarter-over-quarter to $115M.
Based on Michelson Medical Research Foundation's 13F filing for Q3 2025, filed 14 Nov 2025.